The Efficacy of Health Partnership Program for Cancer Patients
1 other identifier
interventional
248
1 country
10
Brief Summary
The Objectives of this study is
- 1.To evaluate the efficacy for exercise, diet, and posttraumatic growth as a result of participating in tailored program (Health Partnership Program) for 24 weeks
- 2.To evaluate the efficacy for quality of life, life satisfaction, health leadership, anxiety, depression, impact of event, social support, cancer belief as a result of participating in tailored program (Health Partnership Program) for 24 weeks
- 3.To assess the efficacy of such intervention compared with usual care in cancer patients
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable breast-cancer
Started Feb 2012
Shorter than P25 for not_applicable breast-cancer
10 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
January 10, 2012
CompletedStudy Start
First participant enrolled
February 1, 2012
CompletedFirst Posted
Study publicly available on registry
February 7, 2012
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 1, 2012
CompletedStudy Completion
Last participant's last visit for all outcomes
June 1, 2013
CompletedFebruary 7, 2012
February 1, 2012
10 months
January 10, 2012
February 6, 2012
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Changes from Baseline in Exercise, Diet, and Posttraumatic Growth Inventory(PTGI)
How much the patient does exercise will be measured using "MET" score. Change in diet will be observed by analyzing 3day recall.
baseline, 3month, 6month, and 12month
Secondary Outcomes (7)
Seven habit profile
baseline, 3month, 6month, and 12month
the European Organisation for the Research and Treatment of Cancer Quality-of-life Questionnaire-Core 30(EORTC QLQ C-30)
baseline, after 3month, 6month, and 12month
Ed Diner's Satisfaction with Life Scale
baseline, after 3month, 6month, and 12month
Impact of Event Scale-Revised
baseline, after 3month, 6month, and 12month
Social Support(MOS-SSS)
baseline, after 3month, 6month, and 12month
- +2 more secondary outcomes
Study Arms (2)
Experimetal Arm
EXPERIMENTALProviding tailored health care program, which provides various information related to exercise, diet, and posttraumatic growth. Tailored health partnership program consists of three strategic areas (exercise, diet, and posttraumatic growth). Those areas are based on the transtheoretical model (TTM), social cognitive theory, PRECEDE-PROCEED model, and Health behavior model. Patients who participate in the tailored health partnership program will be received tailored manual and workbook for tele-coaching that help them to lead their healthy life. Also, patients will be provided a workshop for leadership that is dealt with controlling their healthy life.
Control Arm
NO INTERVENTIONProviding usual care. Also, patients will be provided a workshop for health education that is dealt with ten areas (smoke and drinking, diet, exercise, posttraumatic growth, distress, pain, comorbidity, sleep disturbance, pain, and energy conservation). Twelve month later, patients will be provided the tailored health partnership program which is especially dealing with exercise, diet, and posttraumatic growth.
Interventions
When intervention group participate in the tailored program, they can receive various information which is related with three strategic areas (exercise, diet, and posttraumatic growth). Three areas are based on the transtheoretical model (TTM), social cognitive theory, PRECEDE-PROCEED model, and Health behavior model. Patients will be received tailored manual and workbook for health tele-coaching that help them to lead their healthy life. The health tele-coaching will be operated sixteen times for 24 weeks. Intervention group will be provided three contents (exercise, diet, and posttraumatic growth) from health partners. The health partners took a certificate that is related with health, leadership and coaching. Also, patients will be provided a workshop for leadership that is dealt with controlling their healthy life. It will be proceeded for four hours. Three hours is for the leadership, and the last one hour is for presentation of their health mission statement.
While intervention group participate in the tailored health partnership program, control group can receive various information which is related with ten contents for health management (smoke and drinking, diet, exercise, posttraumatic growth, distress, pain, comorbidity, sleep disturbance, pain, and energy conservation). They will be provided a workshop and booklet for a health education for four hours. Twelve month later, they will be provided the tailored health partnership program which is especially dealing with exercise, diet, and posttraumatic growth as same as the intervention group.
Eligibility Criteria
You may qualify if:
- Adult(≥ 20 years)
- Within 24 months of completion of primary treatment with curative intent (Surgery, radiotherapy, chemotherapy)
- Breast, cervical, colorectal (except rectal cancer), lung, and stomach cancer
- More than two problematic areas among exercise, diet (Fruit \& Vegetable: F\&V), and posttraumatic growth(exercise \< 150min/week, ≥ 3mets, F\&V \< 5/day, PTGI \< 71)
You may not qualify if:
- Evidence of secondary tumor, metastasis and recurrence
- Patients undergoing or planning surgery, radiation therapy or chemotherapy
- Not Korean speaking and reading (Not communication with Korean)
- Not understanding of the study purpose and not written informed consent
- Participants who have an similar study experience
- Major health problem in which exercise/nutrition intervention is contraindicated at the discretion of clinician; cardiovascular disease (congestive heart failure, angina), pulmonary disease (chronic obstructive pulmonary disease, restrictive pulmonary disease), uncontrolled hypertension, poorly controlled diabetes and severe musculoskeletal disease and so on
- Sign of infection (body temperature ≥ 37.2℃ or WBC ≥ 11,000)
- Being pregnant
- Thrombocytopenia (platelet count ≤ 100,000/mcl)
- Anemia (Hb ≤ 10g/dL)
- SGOT or SGPT \> 40 IU/L
- Creatinine \> 1.2 mg/dL
- Severe psychiatric disorder (psychotic disorder, major depression and so on) or suicidal tendencies
- dyspnea
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- National Cancer Center, Korealead
- Samsung Medical Centercollaborator
- Seoul National University Hospitalcollaborator
- Korea University Anam Hospitalcollaborator
- Asan Medical Centercollaborator
- Ajou University School of Medicinecollaborator
- Kyunghee University Medical Centercollaborator
Study Sites (10)
Seoul National University Boondang Hospital
Boondang, Gyunggi, South Korea
National Cancer Center
Goyang, Gyunggi, South Korea
Ajou University Medical Center
Suwon, Gyunggi, South Korea
Keimyng University Dongsan Center
Daegu, South Korea
Asan Medical Center
Seoul, South Korea
Ewha Womans University Mokdong Hospital
Seoul, South Korea
Korea University Anam Hospital
Seoul, South Korea
KyungHee University Medical Center
Seoul, South Korea
Samsung Medical Center
Seoul, South Korea
Seoul National University Hospital
Seoul, South Korea
Related Publications (14)
Eun Sook Lee, M. K. L., Soo Hyun Kim, Jung Sil Ro, Han Sung Kang, Seok Won Kim, Keun Seok Lee, Young Ho Yun. (2010(Accepted) ).
BACKGROUNDKravitz, R. L., D. J. Tancredi, et al. (2009).
BACKGROUNDPark, S. M., M. K. Lim, et al. (2007).
BACKGROUNDShin, H. W., D. Y. Noh, et al. (2009).
BACKGROUNDSoo Hyun Kim, M. S. S., Han Sul Lee, Eun Sook Lee, Jung Sil Ro, Han Sung Kang, Seok Won Kim, Won Hee Lee, Chun Ja Kim, Hee Soon Kim, Joo hyung Kim, Young Ho Yun (2010).
BACKGROUNDStreet, R. L., Jr., C. Slee, et al.
BACKGROUNDVale, M. J., M. V. Jelinek, et al. (2003).
BACKGROUNDWolever, R. Q., M. Dreusicke, et al.
BACKGROUNDDemark-Wahnefried W, Clipp EC, Lipkus IM, Lobach D, Snyder DC, Sloane R, Peterson B, Macri JM, Rock CL, McBride CM, Kraus WE. Main outcomes of the FRESH START trial: a sequentially tailored, diet and exercise mailed print intervention among breast and prostate cancer survivors. J Clin Oncol. 2007 Jul 1;25(19):2709-18. doi: 10.1200/JCO.2007.10.7094.
PMID: 17602076BACKGROUNDKaton WJ, Lin EH, Von Korff M, Ciechanowski P, Ludman EJ, Young B, Peterson D, Rutter CM, McGregor M, McCulloch D. Collaborative care for patients with depression and chronic illnesses. N Engl J Med. 2010 Dec 30;363(27):2611-20. doi: 10.1056/NEJMoa1003955.
PMID: 21190455BACKGROUNDMorey MC, Snyder DC, Sloane R, Cohen HJ, Peterson B, Hartman TJ, Miller P, Mitchell DC, Demark-Wahnefried W. Effects of home-based diet and exercise on functional outcomes among older, overweight long-term cancer survivors: RENEW: a randomized controlled trial. JAMA. 2009 May 13;301(18):1883-91. doi: 10.1001/jama.2009.643.
PMID: 19436015BACKGROUNDZhong B. How to calculate sample size in randomized controlled trial? J Thorac Dis. 2009 Dec;1(1):51-4.
PMID: 22263004BACKGROUNDKim SH, Shin MS, Lee HS, Lee ES, Ro JS, Kang HS, Kim SW, Lee WH, Kim HS, Kim CJ, Kim J, Yun YH. Randomized pilot test of a simultaneous stage-matched exercise and diet intervention for breast cancer survivors. Oncol Nurs Forum. 2011 Mar;38(2):E97-106. doi: 10.1188/11.ONF.E97-E106.
PMID: 21356647BACKGROUNDYun YH, Kim YA, Lee MK, Sim JA, Nam BH, Kim S, Lee ES, Noh DY, Lim JY, Kim S, Kim SY, Cho CH, Jung KH, Chun M, Lee SN, Park KH, Park S. A randomized controlled trial of physical activity, dietary habit, and distress management with the Leadership and Coaching for Health (LEACH) program for disease-free cancer survivors. BMC Cancer. 2017 May 2;17(1):298. doi: 10.1186/s12885-017-3290-9.
PMID: 28464804DERIVED
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
YoungSung Lee, MD, Ph.D
National Cancer Center, Korea
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- SUPPORTIVE CARE
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER GOV
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Head, Division of Cancer Management Branch
Study Record Dates
First Submitted
January 10, 2012
First Posted
February 7, 2012
Study Start
February 1, 2012
Primary Completion
December 1, 2012
Study Completion
June 1, 2013
Last Updated
February 7, 2012
Record last verified: 2012-02